{
    "nct_id": "NCT03611751",
    "official_title": "A Multi-Center, Randomized, Double-Blind, Placebo- and Active Comparator-Controlled Phase 3 Study With Randomized Withdrawal and Retreatment to Evaluate the Efficacy and Safety of BMS-986165 in Subjects With Moderate-to-Severe Plaque Psoriasis",
    "inclusion_criteria": "* Plaque psoriasis for at least 6 months\n* Moderate to severe disease\n* Candidate for phototherapy or systemic therapy\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* Other forms of psoriasis\n* History of recent infection\n* Prior exposure to BMS-986165 or active comparator\n\nOther protocol defined inclusion/exclusion criteria could apply",
    "miscellaneous_criteria": "For more information regarding Bristol-Myers Squibb Clinical Trial participation, please visit www.BMSStudyConnect.com"
}